Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae.
Three hundred and fifty-six bacterial strains, including 107 strains of Pseudomonas aeruginosa, were tested with ceftazidime and five other agents. All bacterial strains were resistant to cefazolin but were sensitive to 32 mg/l of ceftazidime or less.
Thabaut
A
A
Hôpital Militaire Bégin, Saint-Mandé, France.
Durosoir
J L
JL
Saliou
P
P
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002228:Carbenicillin / Q000494:pharmacology; D002437:Cefazolin / Q000494:pharmacology*; D002442:Ceftazidime / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D003470:Culture Media; D024881:Drug Resistance, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D003470:Culture Media; D002442:Ceftazidime; D002228:Carbenicillin; D002437:Cefazolin